US cracks down on investors with Russian, Chinese links

Israel-US
Israel-US

Enhanced regulations governing the Committee on Foreign Investment in the US (CFIUS) go into effect today. How does this affect Israeli investors?

On February 13, 2020, enhanced regulations governing the Committee on Foreign Investment in the United States (CFIUS) will go into effect that increase its authority to review and approve proposed foreign investments in US businesses or real estate. CFIUS has broad jurisdiction and in practice has recently subjected transactions involving Chinese or Russian investors or acquirers to heightened scrutiny to counter perceived threats from those countries. Israeli investors or companies should be aware that CFIUS may encumber their future US investments, especially if those Israeli parties accept funding from or maintain relevant affiliations with Chinese or Russian persons. Israeli financial and strategic investors in US businesses or real estate and joint ventures should consider CFIUS implications early in securing funding and structuring transactions. CFIUS due diligence would especially be relevant in instances where the US business is involved with critical technology, critical infrastructure, or sensitive data or if the US real estate is located close to sensitive US government or other sites as prescribed in the regulations.

CFIUS is empowered to review foreign investments in US businesses (including US operations of foreign businesses) that could result in foreign control of the US business or provide foreign persons with certain non-controlling rights such as access to material nonpublic technical information, board membership or observer rights, or substantive decision-making authority regarding certain topics. CFIUS typically either approves the transaction or imposes conditions to mitigate national security risk.

Although CFIUS has long had authority to unwind, block, or mitigate the risk posed by a transaction where a foreign person gains control of a US business, the new regulations broaden CFIUS’s jurisdiction over certain non-controlling investments and require mandatory filings for some transactions. Israeli investors should be cautious that even minor investments in US businesses may require filing with CFIUS or otherwise face significant penalties, including fines up to the value of the transaction or divestiture.

CFIUS filings are currently mandatory for certain types of investments in US critical technology companies involved with relevant industries listed in the CFIUS regulations. As of February 13th, mandatory filings will also apply with respect to certain investments in a US business involved with critical technology, critical infrastructure, or sensitive data if a foreign government has a "substantial interest" in the investor. These mandatory filing requirements highlight CFIUS’s key national security concerns, which range from traditional threats posed by foreign control or access to defense, telecommunications, or energy locations and infrastructure, to more modern threats posed by aggregated data about US citizens or transfer of sensitive technology.

CFIUS may review covered transactions at any time - including those already consummated - and actively seeks out transactions about which it was not notified. This incentivizes parties to voluntarily undergo CFIUS review in exchange for eliminating the risk of future CFIUS review and mitigation. This future CFIUS risk for completed transactions should be a key consideration for private equity and other repeat investors.

The new rules also contain some exemptions. Investment funds with US general partner(s) and limits on the information and control rights of foreign limited partners may avoid CFIUS review for non-controlling investments. The new regulations also designate Australia, Canada, and the United Kingdom as "excepted foreign states," providing qualified investors from those countries with a similar exemption.

Published by Globes, Israel business news - en.globes.co.il - on February 13, 2020

© Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Intel plant in Kiryat Gat credit:  Intel Intel Israel fate unclear amid TSMC, Broadcom sale talks

"Globes" considers the options for Intel Israel's 9,500 employees if the ailing chip giant is broken up and sold.

BIG Glilot credit: Tel Aviv online BIG Glilot - Israel's biggest shopping center set to open

The shopping center will send shockwaves throughout the retail sector in Tel Aviv and the Sharon region and could put some of the area's malls out of business.

Assaf Rappaport, Gil Shwed and Nadav Zafrir Can Check Point shake off its conservative ways?

The strategic partnership with Wiz is the first major decision by CEO Nadav Zafrir, after 30 years of Gil Shwed's cautious management.

Fintech Photo: Shutterstock Israeli fintech firm valuations plunge despite strong growth

"Globes" examines why Rapyd, Melio and eToro have halved their valuations, even though revenue and profitability are growing.

ERLOS plant in Germany credit: Peter Fenes EV battery recycling plant to open in Israel

Car importer Colmobil is leading the consortium building the plant based on German technology.

The man behind the hostage deal breakthrough

"Globes" profiles Steve Witkoff, the New York real estate businessman turned Middle East envoy.

Donald Trump  credit: Reuters/Brendan McDermid Trump tackles Gaza taboos

Donald Trump's White House press conference with Benjamin Netanyahu put an end to the assumption that he would have a restraining influence on Israeli policy.

Tel Aviv residential towers credit: Tamar Matsafi and Eyal Izhar Location, location, location. How true is it in Tel Aviv?

"Globes" examines prices in residential towers in the city to see whether the old real estate adage applies to Tel Aviv.

Blue agave fields in the Negev  credit: Alon Pearl Alcohol empire rising on Gaza border

Kibbutz Alumim is working on the first Israeli tequila, Kibbutz Beeri aims to establish a whiskey industry, while others dream of producing a world-class wine.

Tal Zaks credit: Dani Machlis Tal Zaks's Israeli startup targets rare genetic diseases

The former Moderna CMO, who led development of the company's Covid vaccine, tells "Globes" about Averna Therapeutics, which through gene editing is developing groundbreaking drugs.

Fazal Merchant credit: Sara Vaz "Within a year Wiz will be ready for an IPO"

In his first interview since being appointed CFO and president of Wiz, Fazal Merchant tells "Globes" about the Israeli cybersecurity company's future plans.

Aaron Frenkel credit: Eli Etkin Aaron Frenkel does it again

With a huge gain on the Bank Leumi stake he sold this week, the Israeli businessman again proved why he is the shrewdest investor on the TASE. "Globes" examines his remarkable track record and current investments.

Shahar Bar-Or credit: Eyal Izhar Infinidat Israel GM: Lenovo will help double our sales

Shahar Bar-Or tells "Globes" about the Herzliya-based enterprise storage startup's revival of fortunes, after it nearly went out of business in 2020, culminating in its $500 million acquisition by Lenovo.

Amit Krig  credit: Shlomi Yosef "People don't come to Nvidia just to earn a little more"

Nvidia SVP Amit Krig talks to "Globes" about the company's extraordinarily rapid expansion in Israel and its appeal to employees.

General (res.) Amos Yadlin  credit: Morag Bitan Amos Yadlin: The battle with Hamas isn't over

Former Military Intelligence chief Yadlin sees the deal with Hamas at this time as morally and strategically correct.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018